
For years, we’ve talked about menopause as though it were primarily an estrogen problem.
Estrogen drops.
Hot flashes begin.
Periods disappear.
End of story.
Except it’s not.
Not even close.
The menopause transition is one of the biggest hormonal and metabolic shifts a woman experiences in her lifetime—and those changes reach far beyond reproductive health.
They affect body composition, glucose metabolism, lipids, blood pressure, vascular function, sleep, inflammation and, ultimately, cardiovascular risk. The American Heart Association now describes perimenopause as an important “window of opportunity” for identifying and addressing cardiovascular risk.
And estrogen isn’t the only hormone involved.
They just don’t matter in exactly the same way.
Estrogen has effects throughout the cardiovascular and metabolic systems.
As ovarian estrogen production changes during perimenopause and eventually declines after menopause, women commonly experience changes in lipid profiles, body composition, insulin sensitivity and vascular health.
LDL cholesterol can rise.
Visceral fat can increase.
Glucose regulation can become less favorable.
Blood pressure may increase.
And these changes can accumulate over time.
Recent U.S. data are particularly interesting: women in perimenopause were about twice as likely to have a low overall cardiovascular-health score compared with women who were still having regular cycles, with cholesterol and blood sugar contributing substantially to the difference.
That’s why I don’t want women thinking about menopause as simply:
“My estrogen is low, so I’m having hot flashes.”
This is where the conversation gets more nuanced.
Progesterone is often treated as the hormone whose only job is to “protect the uterus.”
That’s an oversimplification.
Progesterone and its metabolites interact with the nervous system, sleep, vascular biology and metabolic pathways. And the cardiovascular effects of progesterone itself appear to differ from those of many synthetic progestins used in hormone therapy.
A systematic review found that available evidence suggests micronized progesterone has a relatively neutral vascular and thrombotic profile, although the data are not strong enough to claim that progesterone itself prevents cardiovascular disease.
That’s an important distinction.
We’re not saying:
“Progesterone prevents heart attacks.”
We’re saying:
“The type of progesterone or progestogen matters when we’re considering the overall cardiovascular profile of hormone therapy.”
And that’s a much more sophisticated conversation.
This is the hormone that gets left out of the conversation far too often.
Women produce testosterone too.
And although women have considerably less testosterone than men, it still plays important roles in:
Testosterone levels also decline across the reproductive lifespan, although the relationship between testosterone levels and cardiovascular disease in women is complicated.
And this is where we have to resist the temptation to oversimplify.
But that doesn’t make testosterone irrelevant.
It means we need to understand it properly.
This may be the most important point in the entire conversation.
Your body doesn’t have an estrogen department, a progesterone department, and a testosterone department operating independently.
These hormones interact with one another—and with:
insulin
thyroid hormones
cortisol
lipids
muscle
adipose tissue
sleep
inflammation
blood vessels
and the brain.
So when a woman reaches midlife and suddenly says:
“I don’t recognize my body anymore.”
I don’t want the answer to automatically be:
“You need estrogen.”
Nor do I want it to be:
“Your hormones are normal. Here’s an antidepressant.”
Here’s something I would love to see become routine:
When a woman enters perimenopause, we don’t just ask:
“Are you having hot flashes?”
We also look at her cardiovascular trajectory.
What’s her blood pressure?
What’s happening to her LDL and triglycerides?
What’s her A1c?
What’s happening with her waist circumference and body composition?
Is she maintaining muscle?
How is she sleeping?
What’s her family history?
Does she have risk-enhancing factors?
And depending on her overall risk, are additional cardiovascular assessments appropriate?
Because perimenopause is an opportunity.
The American Heart Association specifically recommends using this period to establish cardiovascular risk and intervene early rather than waiting until after menopause when risk factors may already have accumulated.
Maybe the real mistake we’ve made is talking about menopause as though one hormone disappears and everything else stays the same.
It doesn’t.
The menopause transition is a whole-body transition.
Hormones change.
Metabolism changes.
Body composition changes.
Lipids change.
Vascular biology changes.
Sleep changes.
Muscle changes.
And cardiovascular risk can begin moving in the wrong direction.
That doesn’t mean we’re powerless.
Quite the opposite.
An opportunity to identify what’s changing.
An opportunity to establish your cardiovascular baseline.
An opportunity to protect muscle.
An opportunity to address blood pressure and lipids.
An opportunity to optimize metabolic health.
And, when appropriate, an opportunity to have a thoughtful conversation about hormone therapy.
I don’t want women to wait until they’re 65 to become interested in their cardiovascular health.
By then, we’ve potentially missed years of opportunity.
If you’re entering perimenopause, pay attention.
Not because menopause is dangerous.
But because it’s a major biological transition—and transitions are opportunities to reassess where you’re headed.
Your hormones are part of that conversation.
Your heart is part of that conversation.
Your metabolic health is part of that conversation.
That’s the kind of women’s healthcare I believe in.
Not chasing one hormone number.
Not treating one symptom in isolation.
Not telling women that everything they’re experiencing is “just menopause.”
Because the goal isn’t simply to get through menopause.
The goal is to come out the other side healthier, stronger and ready for the next 30 years.
Essential Woman
Because women’s health was never just about reproduction.
Join our list
Navigate
Contact
Home
About
Service
Blog
FAQ
Contact
Email: Myessentialwoman@gmail.com
Fax: 352-995-0004
1405 SW 6th Ave, Ocala, FL 34471
Licenses
ANCC # 104415489
APRN9191380
Phone: 352-425-1704
Receive updates on special promotions, exclusive events and announcements.
Thank You!